The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
The Food and Drug Administration has issued a safety alert regarding the potential risk of early structural valve deterioration with Abbott Trifecta valves.